Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Ethinyl estradiol-norethindrone Treatment Report
What is Ethinyl estradiol-norethindrone?

The combination of ethinyl estradiol and norethindrone acetate is used for the prevention of pregnancy; treatment of acne; management of menopausal symptoms; and prevention of osteoporosis.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Other 13 2
General health 3 1
Birth control 2 0
Support another treatment 1 0
menstruation differences 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 33%
None
2 67%

Dosages

  1 daily 20 mcg-1 mg daily 20 mg daily 30 daily 35 mcg-1 mg daily triphasic 0.5 mg-0.75 mg-1 mg daily 50 mg daily
  1 Number of Patients: 1 8 Number of Patients: 8 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Ethinyl estradiol-norethindrone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice
3 60% Doctor's advice: 60%
Expense
2 40% Expense: 40%

See all 5 patients who’ve stopped taking Ethinyl estradiol-norethindrone

Currently Taking Ethinyl estradiol-norethindrone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
5
2
3

Stopped Taking Ethinyl estradiol-norethindrone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
2
0
0
3
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
3 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
3 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
1 33%
$50-99
0 0%
$25-49
0 0%
< $25
2 67%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 22, 2009.